Eventide Asset Management - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q1 2022$3,640,000
-63.7%
1,467,922
-12.1%
0.06%
-55.5%
Q4 2021$10,039,000
-9.8%
1,670,3990.0%0.13%
-12.9%
Q3 2021$11,125,000
-53.2%
1,670,399
-53.3%
0.15%
-53.9%
Q2 2021$23,779,000
+44.0%
3,575,834
+100.5%
0.32%
+30.2%
Q1 2021$16,515,0001,783,4880.24%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
ELKHORN PARTNERS LIMITED PARTNERSHIP 45,000$630.04%
FinDec Wealth Services, Inc. 16,000$22,2400.02%
DENVER WEALTH MANAGEMENT, INC. 18,235$25,3470.02%
Atom Investors LP 18,298$25,4340.01%
Laurion Capital Management LP 722,100$1,003,7190.01%
MAI Capital Management 224,749$312,4010.01%
Callan Capital, LLC 31,147$43,2940.01%
GSA CAPITAL PARTNERS LLP 25,975$360.00%
Tortoise Investment Management, LLC 15,000$20,8500.00%
America First Investment Advisors, LLC 4,000$5,5600.00%
View complete list of CARDIFF ONCOLOGY INC shareholders